Schaeffer Center experts analyze the connection between medications for chronic diseases and their impact on Alzheimer’s as well as a lack of representation among racial and ethnic minorities in clinical trials.
Other featured articles
Future Health Dividends for California: Valuing Medical Innovations
Reducing the incidence of four common cancers (breast, colon, lung, and prostate cancer), diabetes and stroke by 50 percent would generate nearly $900 billion in social value for California between 2018 and 2040. Just a 10 percent decline generates $175 billion over the same period.
Are High-Deductible Plans a Healthy Option for Patients?
High-deductible health plans may have unintended consequences for patients.
State-Level Chart Books on the Cost of Mental Illness
As state policymakers assess new proposals to improve mental health treatment and access, understanding the population affected, the coverage gaps and the overall economic burden is integral to developing sustainable solutions that meet the need.
The Future of Cures: Investing in Value, Innovation and Access
High-cost drugs can generate even higher societal value when they combat serious disease, which should be accounted for in financing methods and pricing models to encourage medical innovation.